Theralase Technologies Inc. V.TLT

BIG QUESTION ?????....

[wildbird1]

Why is it that when debbie downers write about TLT, they never talk about TLT great achievements?

1) TLT data are superior to all FDA approved treatments for BCG resistant patients.
2) TLT-Ruvidar Duration Of Response data are also superior to anything out there (including TLT future  competitors).
3) TLT treatment treat patients that no other FDA approved treatments can treat. Because of this TLT is not competing with other FDA approved treatments.
4)Unlike all the other FDA approved treatments, TLT-Ruvidar has no restrictions and is 100% safe(''We treat all patients, all comers, and our data are world class'').
5)The scientific community is beginning to recongnize TLT-Ruvidar as a success story.
6) Because ot its mechanism of action, TLT treatment will be applicable to almost all cancer types(200 Cancer types).
7) TLT future pipeline is huge, starting with Rutherrin. Rutherrin has been show to be effective across numerous potential applications.
-Bladder cancer.
-Immunotherapy.
-Chemotherapy.
-Non small lung cancer.
-Brain cancer.
-Numerous virus.
-ETC....
8) Because TLT is treating patients that no other FDA approved treatments can treat, the FDA badly need TLT-Ruvidar for Unmett Medical Needs(BTD is for Unmett Medical Needs).

Yes the innovative aspect of TLT-Ruvidar is slowing down the FDA approval process,but on the long term, the patients and TLT investors will win big time.

I love the huge upside potential of TLT treatments.
And...
I love my TLT shares.


.

[BlueFranky]

I think I'm referring to you no longer as wild bird..  But as WILD THING !... Keep up the great work! https://youtu.be/v7f9038oIgs?si=fZUHSC393yQeV7iR

[N0taP00p]

Repeating and visualizing what success looks like on a daily basis (with a set menu.of words) does not actually mean success. All those are good points and everyone invested because of that. But we want to move beyond the  perpetual admiration of St Peter's gate. 

[Longholder99]

Bashers don't usually get paid to be accurate. They get paid to form a  narrative for hopeful SP  suppression to the benefit of whomever is paying them.  Just my opinion mind you.....do your own research and all that. 

[Legit62]

Thats a good point Longholder but i dont believe our problem is with the negatives or bashers on here, i think its missed time lines one after the other and no derisking yet, putting a drug to market is no easy task thats why i stay positive and invested, plus i like Roger is keeping this in house, even though its hurting SP now with all the teeny weeny PPs. Got to stay focused on the prize which

[Longholder99]

Totally agree Legit.  My comment was mostly directed at the one observation.  We need to get de risked either from the study position or financing.  The prospect of another PP and the unknown future for our financing in general is certainly behind a lot of hesitation in my opinion.  Once one or more of these risk factors disappears and I do believe fomo can take over. 

[N0taP00p]

You just need to hit one more button on the elevator for the top floor, buddy. Aren't you saying the same thing as the dreaded bashers (we need validation via BTD and we need better financing)?  It's a head scratcher, but very amusing. 

[zombize]

I assure you I am not a paid basher...I stand to lose a *lot* if TLT goes south, I've just been to enough of these rodeos to be suspicious when I start to feel like I know something that the market doesn't, lol

[McBullish]

I think this stock needs validation and it will be off to the races. The BTD/AA designation would be huge, as would a grant. If it uplists to Nasdaq the speculation alone here could drive this way up. No one knows about TLT yet.  The biggest risk here is the short and repetitive funding windows and missed dates. Im invested in several speculative tech and bio stocks. What I have learned is

[Alamir1111]

Got a question what chances does tlt have on nasdq with the current leadership?

[McBullish]

Thats a great question. I havent been around long enough to comment on that but I am sure others here can. I guess we'll see where we are here in the next 90 days if they pull off BTD. There has to be measureable success for it to be taken seriously. Uplisting isnt always a good thing but I think the exposure alone could be huge for TLT. In the US we have to trade TLT as an OTC so its a much

[Alamir1111]

https://stockanalysis.com/list/otc-stocks/

[zombize]

I am well aware of the acheivements, and I'm not being a downer - I just don't think I'm smart enough to outsmart the market. The numbers really do seem like they should speak for themselves, which makes it all the weirder than bigger players aren't jumping on board. I don't for a second think that I know more than they do, and I often wonder what they know that I don't

[Legit62]

What they know is that they cant trade at this low price on our exchange, and until our SP jumps expect no big buys, once BTD and AA we should get to a price from us small-sum investors where hopefully we move to a more regulated exchange, then big things happen

[StevenBirch]

The question is why do the skeptics always seem to surface right around the same time a PP looks imminent? And when I say imminent it's because all of a sudden 225k from TD shows up at 28 cents, they always seem to predict these PPs. So lack of volume or lack of interest are not the reason we are here. It's the uncertainty of when we will see the last of the PPs and that is most likely

[Alamir1111]

Thx Steven for explaining the  situation  of a sudden 225k from TD shows up at 28 cents, they always seem to predict these PPs. So lack of volume or lack of interest are not the reason we are here. I

[zombize]

Its really not a conspiracy man, im in this the same as you. You can question a stock on legitimate grounds without being a basher. Nothing suspicious about it, ive been posting for a long a$$ time and im invested. 

[Maxcitrac]

Excellent point StevenBirch, another good question is why the skeptic (Infinity,NotaPoop......) are always trying to discredit Theralase management, and at the same time pushing for a big pharma takeover. I see only one good reason, there is a big pharma out there trying to get Theralase for peanuts, this big pharma know that Theralase treatment will be a big disruptor in the cancer field, and

[N0taP00p]

Nice make-believe world you live in, Maxi. Far be it from me to rock your boat. The skepticism is based on past performance,  rinsed and repeated over a decade, while we hold a ton of shares. For some, every delay and dilution is cause for more misleading projections and delusions of grandeur.  $100 stock price, imminent buyout, JV,  etc. For others, it's a recalibration of the

[bmk211]

I can't find one thing wrong with this stock.